At CDMO Live Europe 2026, Giulio Cavalli, Principal Lead External Manufacturing, J&J Innovative Medicine; Neil Stevenson, Director, CMC Logic Consultancy; Marine Joly Battaglini, Founder, PharmDev; and Susan Reasoner, Chief Commercial Officer, BioDuro, examined how early-stage biotechs can avoid common selection mistakes, manage capacity concerns, and build CDMO relationships designed to last beyond Phase 1.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from PharmaSource Podcast
Container Closure Integrity: 6 Considerations for Evaluating CDMO Capabilities
What Changes When Pharma Outsources Outcomes, Not Just People?
Europe Needs to Pick a Side: Why Geopolitics Is Forcing a Rethink of Pharma Supply Network Design
AI in Biopharma Manufacturing: Why Build-or-Buy Is the Wrong First Question
Get summaries like this every morning.
Free AI-powered recaps of PharmaSource Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.